Monte Rosa Therapeutics’ Global Licensing Collaboration with Novartis

Leila Ahmed
Tagged:

Ropes & Gray advised Monte Rosa Therapeutics on the transaction. Monte Rosa Therapeutics (Nasdaq: GLUE) has entered into a global exclusive licensing agreement with Novartis to…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here